John A. Lewicki, Chief Scientific Officer at Mereo BioPharma Group plc (MREO), sold 41,032 shares at $3.39 ($141K) on 2024-06-26, disclosed to the SEC on 2024-06-27.
Open-market sale of $141k MREO by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.69 | 7,416 | $27K | 19.4% |
| 2 | $3.39 | 16,808 | $57K | 40.3% |
| 3 | $3.39 | 16,808 | $57K | 40.3% |
| Total | $3.44 avg | 41,032 | $141K | 100% |
| Filing → |
| OMED | SELL | 2018-10-10 | $5K | — | Filing → |
| OMED | SELL | 2018-04-26 | $12K | — | Filing → |
| OMED | SELL | 2017-10-12 | $5K | — | Filing → |